{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-031420","form_type":"8-K","ticker":"TBPH","cik":"0001583107","company_name":"Theravance Biopharma, Inc.","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.706697+00:00","generated_at":"2026-06-18T04:27:16.832843+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Theravance Biopharma confirms zero exposure to Silicon Valley Bank","bullets":["Company states it holds no cash deposits or securities at Silicon Valley Bank.","Disclosure addresses potential investor concerns about SVB's March 2023 collapse.","No financial impact or operational disruption related to SVB's failure."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-031420","json":"https://secwatch.observer/filing/0001104659-23-031420.json","markdown":"https://secwatch.observer/filing/0001104659-23-031420.md","text":"https://secwatch.observer/filing/0001104659-23-031420.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583107/000110465923031420/0001104659-23-031420-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583107/000110465923031420/tm239223d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:27:16.832843+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}